Taken together with our observation that combinational treatment with neutralizing antibodies targeting Notch1 and VEGFA synergistically reduces the development of breast tumors in xenograft models, our data indicate that disruption of the interaction between tumor cells and their perivascular niches would severely diminish the aggressiveness of breast cancer in vitro and in vivo. Here, NOTCH1 is linked to neoplasm.